Invasive glioblastoma cells acquire stemness and increased Akt activation.
暂无分享,去创建一个
M. Georgescu | Maria-Magdalena Georgescu | Clifton Stephens | Jennifer R. Molina | Jennifer R Molina | Yuho Hayashi | C. Stephens | Y. Hayashi | J. Molina
[1] L. Chin,et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.
[2] Yuri Kotliarov,et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.
[3] M. Westphal,et al. Glioma invasion in the central nervous system. , 1996, Neurosurgery.
[4] H. Hanafusa,et al. Biological Effects of c-Mer Receptor Tyrosine Kinase in Hematopoietic Cells Depend on the Grb2 Binding Site in the Receptor and Activation of NF-κB , 1999, Molecular and Cellular Biology.
[5] H. Hanafusa,et al. PTEN Induces Cell Cycle Arrest by Decreasing the Level and Nuclear Localization of Cyclin D1 , 2003, Molecular and Cellular Biology.
[6] Ali H. Brivanlou,et al. Signaling Pathways in Cancer and Embryonic Stem Cells , 2007, Stem Cell Reviews.
[7] P. Kleihues,et al. Genetic pathways to primary and secondary glioblastoma. , 2007, The American journal of pathology.
[8] H. Clevers,et al. Stem cells, self-renewal, and differentiation in the intestinal epithelium. , 2009, Annual review of physiology.
[9] I. Jonassen,et al. Angiogenesis-independent tumor growth mediated by stem-like cancer cells , 2006, Proceedings of the National Academy of Sciences.
[10] Erwin G. Van Meir,et al. Tumor initiating cells in malignant gliomas: biology and implications for therapy , 2009, Journal of Molecular Medicine.
[11] M. Georgescu,et al. Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma. , 2010, Neuro-oncology.
[12] Seung-Hoon Lee,et al. Role of hyaluronan in glioma invasion , 2008, Cell adhesion & migration.
[13] Yoko Takahashi,et al. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling , 2006, The EMBO journal.
[14] H. Hanafusa,et al. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] L. S. Harrington,et al. Restraining PI3K: mTOR signalling goes back to the membrane. , 2005, Trends in biochemical sciences.
[16] Khalid Shah,et al. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. , 2009, Cancer research.
[17] E. Radaelli,et al. Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease. , 2009, Histology and histopathology.
[18] K. Moelling,et al. Phosphorylation and regulation of Raf by Akt (protein kinase B). , 1999, Science.
[19] Magnus Bosse,et al. Regulation of Raf-Akt Cross-talk , 2002, The Journal of Biological Chemistry.
[20] Michael E. Berens,et al. Glioma Cell Motility is Associated with Reduced Transcription of Proapoptotic and Proliferation Genes: A cDNA Microarray Analysis , 2001, Journal of Neuro-Oncology.
[21] Yoko Takahashi,et al. Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Georgescu,et al. Random selection: a model for poliovirus infection of the central nervous system. , 1997, The Journal of general virology.
[23] A. Newton,et al. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. , 2005, Molecular cell.
[24] Daniel J Brat,et al. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. , 2004, The international journal of biochemistry & cell biology.
[25] R. Bjerkvig,et al. Stimulation of extracellular matrix components in the normal brain by invading glioma cells , 1998, International journal of cancer.
[26] R. Bjerkvig,et al. Migratory pattern of fetal rat brain cells and human glioma cells in the adult rat brain. , 1993, Cancer research.
[27] R. Beroukhim,et al. Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis. , 2009, Cancer cell.
[28] W. Arap,et al. Bottom-Up Assembly of Hydrogels from Bacteriophage and Au Nanoparticles: The Effect of Cis- and Trans-Acting Factors , 2008, PloS one.
[29] K. Kalland,et al. Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell‐like phenotype , 2009 .
[30] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[31] A. Newton,et al. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. , 2007, Molecular cell.
[32] I. Bayazitov,et al. A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.
[33] M. Sulis,et al. PTEN: from pathology to biology. , 2003, Trends in cell biology.
[34] Yong Yang,et al. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. , 2009, Cancer letters.
[35] W. K. Alfred Yung,et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.
[36] G. Fuller,et al. An implantable guide-screw system for brain tumor studies in small animals. , 2000, Journal of neurosurgery.
[37] James A Bankson,et al. Three-dimensional tissue culture based on magnetic cell levitation. , 2010, Nature nanotechnology.
[38] M. Berens,et al. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. , 2007, Journal of the National Cancer Institute.